Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Van Ostade, Xaveer*" or (type exact bookEditor and editor="Van Ostade, Xaveer*")

Add to list
- Journal Article
- A1
- open access
Covalent cysteine targeting of Bruton's tyrosine kinase (BTK) family by withaferin-A reduces survival of glucocorticoid-resistant multiple myeloma MM1 cells

Emilie Logie, Chandra S. Chirumamilla, Claudina Perez-Novo, Priyanka Shaw, Ken Declerck, Ajay Palagani, Savithri Rangarajan, Bart Cuypers, Nicolas De Neuter, Fazil Mobashar Hussain Urf Turabe, et al.

(2021) CANCERS. 13(7).
Add to list
- Journal Article
- A1
- open access
The CD147 protein complex is involved in entry of Chikungunya virus and related alphaviruses in human cells

Lien De Caluwe, Sandra Coppens, Katleen Vereecken, Simon Daled (UGent) , Maarten Dhaenens (UGent) , Xaveer Van Ostade, Dieter Deforce (UGent) , Kevin K. Arien and Koen Bartholomeeusen

(2021) FRONTIERS IN MICROBIOLOGY. 12.
Add to list
- Journal Article
- A1
Proteomic characterization of Withaferin A-targeted protein networks for the treatment of monoclonal myeloma gammopathies

Martin Dom, Fritz Offner (UGent) , Wim Vanden Berghe and Xaveer Van Ostade

(2018) JOURNAL OF PROTEOMICS. 179. p.17-29
Add to list
- Journal Article
- A1
- open access
Selective glucocorticoid receptor properties of GSK866 analogs with cysteine reactive warheads

Chandra S Chirumamilla, Ajay Palagani, Balu Kamaraj, Ken Declerck, Marinus WC Verbeek, Oksana Ryabtsova, Karolien De Bosscher (UGent) , Nadia Bougarne, Bart Ruttens (UGent) , Kris Gevaert (UGent) , et al.

(2017) FRONTIERS IN IMMUNOLOGY. 8.
Add to list
- Journal Article
- A1
The proteome of the human neuroblastoma cell line SH-SY5Y: an enlarged proteome

Kambiz Gilany, Roos Van Elzen, Kim Mous, Edmond Coen, Walter Van Dongen, Stefaan Vandamme, Kris Gevaert (UGent) , Evy Timmerman (UGent) , Joël Vandekerckhove (UGent) , Sylvia Dewilde, et al.

(2008) BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS. 1784(7-8). p.983-985
Add to list
- Journal Article
- A1
MAPPIT: a cytokine receptor-based two-hybrid method in mammalian cells.

Jan Tavernier (UGent) , Sven Eyckerman (UGent) , Irma Lemmens (UGent) , J VAN DER HEYDEN, Joël Vandekerckhove (UGent) and Xaveer Van Ostade

(2002) CLINICAL AND EXPERIMENTAL ALLERGY. 32(10). p.1397-1404
Add to list
- Journal Article
- A1
Down-modulation of type 1 interferon responses by receptor cross-competition for a shared Jak kinase

E Dondi, Els Pattyn, G Lutfalla, Xaveer Van Ostade, G Uze, S Pellegrini and Jan Tavernier (UGent)

(2001) JOURNAL OF BIOLOGICAL CHEMISTRY. 276(50). p.47004-47012
Add to list
- Journal Article
- A1
Design and application of a cytokine-receptor-based interaction trap.

Sven Eyckerman (UGent) , A VERHEE, J VAN DER HEYDEN, Irma Lemmens (UGent) , Xaveer Van Ostade, Joël Vandekerckhove (UGent) and Jan Tavernier (UGent)

(2001) NATURE CELL BIOLOGY. 3(12). p.1114-1119
Add to list
- Journal Article
- A1
A sensitive and versatile bioassay for ligands that signal through receptor clustering

Xaveer Van Ostade, Liesbeth Schauvliege, Els Pattyn, Annick Verhee (UGent) , Joël Vandekerckhove (UGent) and Jan Tavernier (UGent)

(2000) JOURNAL OF INTERFERON AND CYTOKINE RESEARCH. 20(1). p.79-87
Add to list
- Journal Article
- A1
Interleukin 5 regulates the isoform expression of its own receptor alpha-subunit.

Jan Tavernier (UGent) , J VAN DER HEYDEN, A VERHEE, Guy Brusselle (UGent) , Xaveer Van Ostade, Joël Vandekerckhove (UGent) , J NORTH, SM RANKIN, AB KAY and DS ROBINSON

(2000) BLOOD. 95(5). p.1600-1607
Add to list
- Miscellaneous
Analysis of the Expression Pattern of Human Interleukin-5 Receptor a Isoforms in Vitro

Jan Tavernier (UGent) , A VERHEE, Joël Vandekerckhove (UGent) , Xaveer Van Ostade and J VAN DER HEYDEN

(1999) Interleukin-5, from Molecule to Drug Target for Asthma, Eds. Marcel Dekker Inc. 1999.
Add to list
- Journal Article
- A1
The cell surface expression level of the human interleukin-5 receptor alpha subunit determines the agonistic/antagonistic balance of the human interleukin-5 E13Q mutein.

Xaveer Van Ostade, J VAN DER HEYDEN, A VERHEE, Joël Vandekerckhove (UGent) and Jan Tavernier (UGent)

(1999) EUROPEAN JOURNAL OF BIOCHEMISTRY. 259(3). p.954-960
Add to list
- Journal Article
- A1
Human tumor necrosis factor mutants with preferential binding to and activity on either the R55 or R75 receptor.

Xaveer Van Ostade, Peter Vandenabeele (UGent) , Jan Tavernier (UGent) and Walter Fiers

(1994) EUROPEAN JOURNAL OF BIOCHEMISTRY. 220(3). p.771-779
Add to list
- Journal Article
- A1
Structure-activity studies of human tumour necrosis factors.

Xaveer Van Ostade, Jan Tavernier (UGent) and Walter Fiers

(1994) PROTEIN ENGINEERING. 7(1). p.5-22
Add to list
- Conference Paper
- C1
Two pathways of tumor necrosis factor signal transduction: in vitro and in vivo implications

Walter Fiers, Rudi Beyaert (UGent) , Peter Brouckaert (UGent) , Anje Cauwels (UGent) , Wim Declercq (UGent) , Dirk De Valck, B Everaerdt, Vera Goossens (UGent) , Johan Grooten (UGent) , Guy Haegeman (UGent) , et al.

(1993) Tumor necrosis factor : molecular and cellular biology and clinical relevance. p.58-65
Add to list
- PhD Thesis
Struktuur-funktie onderzoek van tumor nekrosis faktor

Xaveer Van Ostade

(1993)
Add to list
- Journal Article
- A1
HUMAN TNF MUTANTS WITH SELECTIVE ACTIVITY ON THE P55 RECEPTOR.

Xaveer Van Ostade, Peter Vandenabeele (UGent) , Bart Everaerdt, H LOETSCHER, R GENTZ, M BROCKHAUS, W LESSLAUER, Jan Tavernier (UGent) , Peter Brouckaert (UGent) and Walter Fiers

(1993) NATURE. 361(6409). p.266-269
Add to list
- Conference Paper
- P1
Tumor-necrosis-factor : mechanism of action at the molecular, cellular and in vivo level

Walter Fiers, Rudi Beyaert (UGent) , Peter Brouckaert (UGent) , Els Decoster, Dirk De Valck, Bart Everaerdt, Johan Grooten (UGent) , Anne Lenaerts, Claude Libert (UGent) , K. Schulzeosthoff, et al.

(1992) TUMOR NECROSIS FACTOR : STRUCTURE-FUNCTION RELATIONSHIP AND CLINICAL APPLICATION. p.66-73
Add to list
- Conference Paper
- C1
Tumor necrosis factor : mechanism of action and its potential for anticancer therapy

W Hers, Rudi Beyaert (UGent) , Peter Brouckaert (UGent) , Els Decoster, Dirk De Valck, B Everaerdt, Johan Grooten (UGent) , Anne Lenaerts, Claude Libert (UGent) , K Schulze-Osthoff, et al.

(1992) Molecular aspects of chemotherapy : proceedings of the third international symposium. p.116-125
Add to list
- Journal Article
- A1
Expression of an exogenous tumor-necrosis-factor (TNF) gene in TNF-sensitive cell-lines confers resistance to TNF-mediated cell-lysis.

Bart Vanhaesebroeck, Els Decoster, Xaveer VAN OSTADE, S VANBLADEL, Anne Lenaerts, Frans Van Roy (UGent) and Walter Fiers

(1992) JOURNAL OF IMMUNOLOGY. 148(9). p.2785-2794
Add to list
- Journal Article
- A1
Localization of the active site of human tumour necrosis factor (hTNF) by mutational analysis

Xaveer Van Ostade, Jan Tavernier (UGent) , Thierry Prangé and Walter Fiers

(1991) EMBO JOURNAL. 10(4). p.827-836
Add to list
- Journal Article
- A1
Tumor-necrosis-factor : mechanism of action at the molecular, cellular and in vivo level

Walter Fiers, Rudi Beyaert (UGent) , Peter Brouckaert (UGent) , Bart Everaerdt, Johan Grooten (UGent) , Anne Lenaerts, Claude Libert (UGent) , P. Suffys, Nozomi Takahashi (UGent) , Jan Tavernier (UGent) , et al.

(1990) SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION. 50(Suppl 202). p.159-159
Add to list
- Journal Article
- A1
Analysis of the structure-function relationship of tumour necrosis factor: human/mouse chimeric TNF proteins: general properties and epitope analysis

Jan Tavernier (UGent) , Anne Marmenout, Rita Bauden, Guido Hauquier, Xaveer Van Ostade and Walter Fiers

(1990) JOURNAL OF MOLECULAR BIOLOGY. 211(2). p.493-501
Add to list
- Conference Paper
- P1
In vitro and in vivo action of tumor necrosis factor

Walter Fiers, Rudi Beyaert (UGent) , Peter Brouckaert (UGent) , Bart Everaerdt, Guy Haegeman (UGent) , Claude Libert (UGent) , Philip Suffys, Nozomi Takahashi, Jan Tavernier (UGent) , Sigrid Van Bladel, et al.

(1990) Tumor necrosis factor : structure, mechanism of action, role in disease and therapy. p.77-81
Add to list
- Journal Article
- A1
Two conserved tryptophan residues of tumor necrosis factor and lymphotoxin are not involved in the biological activity

Xaveer Van Ostade, Jan Tavernier (UGent) and Walter Fiers

(1988) FEBS LETTERS. 238(2). p.347-352
Add to list
- Journal Article
- A1
Gene cloning and structure: function relationship of cytokines such as TNF and interleukins

Walter Fiers, Rudi Beyaert (UGent) , Peter Brouckaert (UGent) , Bart Everaerdt, Guy Haegeman (UGent) , Philip Suffys, Jan Tavernier (UGent) , Peter Vandenabeele (UGent) , Bart Vanhaesebroeck, Xaveer Van Ostade, et al.

(1987) IMMUNOLOGY LETTERS. 16(3-4). p.219-226

Academic Bibliography

Covalent cysteine targeting of Bruton's tyrosine kinase (BTK) family by withaferin-A reduces survival of glucocorticoid-resistant multiple myeloma MM1 cells

The CD147 protein complex is involved in entry of Chikungunya virus and related alphaviruses in human cells

Proteomic characterization of Withaferin A-targeted protein networks for the treatment of monoclonal myeloma gammopathies

Selective glucocorticoid receptor properties of GSK866 analogs with cysteine reactive warheads

The proteome of the human neuroblastoma cell line SH-SY5Y: an enlarged proteome

MAPPIT: a cytokine receptor-based two-hybrid method in mammalian cells.

Down-modulation of type 1 interferon responses by receptor cross-competition for a shared Jak kinase

Design and application of a cytokine-receptor-based interaction trap.

A sensitive and versatile bioassay for ligands that signal through receptor clustering

Interleukin 5 regulates the isoform expression of its own receptor alpha-subunit.

Analysis of the Expression Pattern of Human Interleukin-5 Receptor a Isoforms in Vitro

The cell surface expression level of the human interleukin-5 receptor alpha subunit determines the agonistic/antagonistic balance of the human interleukin-5 E13Q mutein.

Human tumor necrosis factor mutants with preferential binding to and activity on either the R55 or R75 receptor.

Structure-activity studies of human tumour necrosis factors.

Two pathways of tumor necrosis factor signal transduction: in vitro and in vivo implications

Struktuur-funktie onderzoek van tumor nekrosis faktor

HUMAN TNF MUTANTS WITH SELECTIVE ACTIVITY ON THE P55 RECEPTOR.

Tumor-necrosis-factor : mechanism of action at the molecular, cellular and in vivo level

Tumor necrosis factor : mechanism of action and its potential for anticancer therapy

Expression of an exogenous tumor-necrosis-factor (TNF) gene in TNF-sensitive cell-lines confers resistance to TNF-mediated cell-lysis.

Localization of the active site of human tumour necrosis factor (hTNF) by mutational analysis

Tumor-necrosis-factor : mechanism of action at the molecular, cellular and in vivo level

Analysis of the structure-function relationship of tumour necrosis factor: human/mouse chimeric TNF proteins: general properties and epitope analysis

In vitro and in vivo action of tumor necrosis factor

Two conserved tryptophan residues of tumor necrosis factor and lymphotoxin are not involved in the biological activity

Gene cloning and structure: function relationship of cytokines such as TNF and interleukins

Contents

Support

Contact